We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Team Design Drug Molecule to Improve Heart Attack Recovery

News   Aug 20, 2019 | Original story from Virginia Tech

 
Team Design Drug Molecule to Improve Heart Attack Recovery

Robert Gourdie, a professor at the Fralin Biomedical Research Institute at VTC, is working on a way to limit the damage of hypoxic ischemic injury, while allowing the nearby heart muscle cells to remain intact. Credit: Virginia Tech

 
 
 

RELATED ARTICLES

Making Chemotherapy More Effective Against Pancreatic Cancer

News

Using patient cell lines and tumor-bearing models, researchers have discovered that inhibition of GSK-3, an enzyme involved in many cancer-promoting processes, sensitizes pancreatic cancer cell lines to gemcitabine, the most commonly used chemotherapy.

READ MORE

Senescent Cell Burden Is Reduced in Humans by Senolytic Drugs

News

In a small safety and feasibility clinical trial, Mayo Clinic researchers have demonstrated for the first time that senescent cells can be removed from the body using drugs termed “senolytics”.

READ MORE

New Study of HIV Vaccine Shows Promising Results Across Strains

News

Using the same RV 144 HIV vaccine employed in Thailand, a new study has evaluated whether the vaccine-induced immune responses to RV 144 are similar in a South African cohort.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE